Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 25295 

detailed data and other information on 

firms operating in FTZs in the United 

States, and under similar programs in 

Canada, and Mexico. Such information 

is not available in the requested 

specificity from governmental and other 

public sources. The Commission 

indicated in its notice of investigation 

that it will need to obtain much of such 

data and information through a survey. 

The survey will assist the Commission 

in developing, as requested, an 

overview of economic activity and 

policies and practices in U.S. FTZs and 

under similar programs in Canada and 

Mexico, and the effects of those policies 

and practices on the cost 

competitiveness of products of firms 

operating in these programs. Similar 

programs in Canada include the Duties 

Relief Program, Drawback Program, 

Export Distribution Center Program, and 

Exporters of Processing Services 

Program. Similar programs in Mexico 

include Industria Manufacturera, 

Maquiladora y de Servicios de 

Exportacio ́n (IMMEX), Value Added Tax 

(VAT)/Special Tax on Production and 

Services (IEPS) Certification, Programa 

de Promocio ́n Sectorial (PROSEC), Rule 

8 (Regla 8), and Operadores Econo ́micos 

Autorizados (OEA) (previously Nuevo 

Esquema de Empresas Certificadas 

(NEEC)). 

Summary of Proposal: The 

Commission intends to submit the 

following draft information collection 

plan to OMB and invites public 

comment. 

(1) Number of forms submitted: 1. 

(2) Title of form: Foreign Trade Zones 

Questionnaire. 

(3) Type of request: New. 

(4) Frequency of use: Industry 

questionnaire, single data gathering, 

scheduled for 2022. 

(5) Description of respondents: U.S. 

firms granted authority, and exercising 

this authority, to produce in a U.S. FTZ. 

(6) Estimated number of respondents: 

400. 

(7) Estimated total number of hours to 

complete the questionnaire per 

respondent: 20 hours. 

(8) Information obtained from the 

questionnaire that qualifies as 

confidential business information will 

be so treated by the Commission and not 

disclosed in a manner that would reveal 

the individual operations of a business. 

Method of Collection: Respondents 

will be sent a letter with a link and 

individual code for accessing the online 

form. Once the online form is complete, 

respondents will be directed to submit 

the form by selecting a submit button. 

Request for Comments: Comments are 

invited on (1) the draft questionnaire; 

(2) whether the proposed collection of 

information is necessary; (3) the 

accuracy of the agency’s estimate of the 

burden (including hours and cost) of the 

proposed collection of information; (4) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (5) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. 

The draft questionnaire and other 

supplementary documents may be 

downloaded from the USITC website at 

https://www.usitc.gov/ftzinvestigation. 

Comments submitted in response to 

this notice will be summarized and 

included in the request for OMB 

approval of this information collection; 

they will also become a matter of public 

record. As such proprietary or 

confidential business information 

should not be submitted as part of 

comments on the draft questionnaire. 

By order of the Commission. 

Issued: April 25, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–09115 Filed 4–27–22; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1000] 

Importer of Controlled Substances 

Application: Lipomed 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Lipomed has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplemental Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before May 31, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

May 31, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on February 9, 2022, 150 

Cambridgepark Drive, Suite 705, 

Cambridge, Massachusetts 02140, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug code Schedule 

3-Fluoro-N-methylcathinone (3-FMC) .............................................................................................................................. 1233 I 

Cathinone ........................................................................................................................................................................ 1235 I 

Methcathinone ................................................................................................................................................................. 1237 I 

4-Fluoro-N-methylcathinone (4-FMC) .............................................................................................................................. 1238 I 

Pentedrone (a-methylaminovalerophenone) ................................................................................................................... 1246 I 

Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 1248 I 

4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................ 1249 I 

Naphyrone ....................................................................................................................................................................... 1258 I 

N-Ethylamphetamine ....................................................................................................................................................... 1475 I 


jspears on DSK121TN23PROD with NOTICES1
25296 Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 

Controlled substance Drug code Schedule 

N,N-Dimethylamphetamine .............................................................................................................................................. 1480 I 

Fenethylline ..................................................................................................................................................................... 1503 I 

Aminorex .......................................................................................................................................................................... 1585 I 

4-Methylaminorex (cis isomer) ........................................................................................................................................ 1590 I 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Methaqualone .................................................................................................................................................................. 2565 I 

Mecloqualone .................................................................................................................................................................. 2572 I 

JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ................................................................................................... 6250 I 

SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................. 7008 I 

ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............. 7010 I 

5-Fluoro-UR-144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone) .............. 7011 I 

AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...................... 7012 I 

JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) ....................................................................................................................... 7019 I 

MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ....................... 7020 I 

FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3- 

methylbutanoate).

7021 I 

AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide .......................................... 7023 I 

THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) ................................................................. 7024 I 

5-AB-PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ......................... 7025 I 

AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ................ 7031 I 

MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ......... 7032 I 

5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ............................................... 7033 I 

5F-ADB; 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ........ 7034 I 

ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................. 7035 I 

Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido) 3,3-dimethylbutanoate) ........................................................... 7036 I 

MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3- 

dimethylbutanoate).

7042 I 

MMB-CHMICA , AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ........ 7044 I 

N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboximide) .............................................................................. 7047 I 

APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ............................................................ 7048 I 

5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .................................... 7049 I 

JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ................................................................................................... 7081 I 

1-(5-Fluoropentyl)-1H-indazole-3-carboxamide ............................................................................................................... 7083 I 

5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) ................. 7085 I 

4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78 

(1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboximide).

7089 I 

SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ..................................................................... 7104 I 

JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .............................................................................. 7118 I 

JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ...................................................................................................... 7122 I 

UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ................................................................ 7144 I 

JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................ 7173 I 

JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ........................................................................................... 7200 I 

AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ....................................................................................................... 7201 I 

JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ...................................................................................................... 7203 I 

NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ......................................................... 7221 I 

PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .................................................................................................. 7222 I 

5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) .............................................................................. 7225 I 

4-methyl-alpha-ethylaminopentiophenone (4-MEAP) ...................................................................................................... 7245 I 

N-ethylhexedrone ............................................................................................................................................................ 7246 I 

Alpha-ethyltryptamine ...................................................................................................................................................... 7249 I 

Ibogaine ........................................................................................................................................................................... 7260 I 

CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ................................................................. 7297 I 

CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ........................................... 7298 I 

Lysergic acid diethylamide .............................................................................................................................................. 7315 I 

2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ................................................................................................ 7348 I 

Marihuana extract ............................................................................................................................................................ 7350 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

Parahexyl ......................................................................................................................................................................... 7374 I 

Mescaline ......................................................................................................................................................................... 7381 I 

2C-T-2, (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine) ............................................................................................ 7385 I 

3,4,5-Trimethoxyamphetamine ........................................................................................................................................ 7390 I 

4-Bromo-2,5-dimethoxyamphetamine ............................................................................................................................. 7391 I 

4-Bromo-2,5-dimethoxyphenethylamine .......................................................................................................................... 7392 I 

4-Methyl-2,5-dimethoxyamphetamine ............................................................................................................................. 7395 I 

2,5-Dimethoxyamphetamine ............................................................................................................................................ 7396 I 

JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ...................................................................................................... 7398 I 

2,5-Dimethoxy-4-ethylamphetamine ................................................................................................................................ 7399 I 

3,4-Methylenedioxyamphetamine .................................................................................................................................... 7400 I 

5-Methoxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7401 I 

N-Hydroxy-3,4-methylenedioxyamphetamine .................................................................................................................. 7402 I 

3,4-Methylenedioxy-N-ethylamphetamine ....................................................................................................................... 7404 I 

3,4-Methylenedioxymethamphetamine ............................................................................................................................ 7405 I 

4-Methoxyamphetamine .................................................................................................................................................. 7411 I 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 25297 

Controlled substance Drug code Schedule 

5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. 7431 I 

Alpha-methyltryptamine ................................................................................................................................................... 7432 I 

Bufotenine ........................................................................................................................................................................ 7433 I 

Diethyltryptamine ............................................................................................................................................................. 7434 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

Psilocybin ......................................................................................................................................................................... 7437 I 

Psilocyn ........................................................................................................................................................................... 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 7439 I 

4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ............................................................................................ 7443 I 

N-Ethyl-1-phenylcyclohexylamine .................................................................................................................................... 7455 I 

1-(1-Phenylcyclohexyl)pyrrolidine .................................................................................................................................... 7458 I 

1-[1-(2-Thienyl)cyclohexyl]piperidine ............................................................................................................................... 7470 I 

1-[1-(2-Thienyl)cyclohexyl]pyrrolidine .............................................................................................................................. 7473 I 

N-Ethyl-3-piperidyl benzilate ............................................................................................................................................ 7482 I 

N-Methyl-3-piperidyl benzilate ......................................................................................................................................... 7484 I 

N-Benzylpiperazine .......................................................................................................................................................... 7493 I 

4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) ..................................................................................................... 7498 I 

2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) .................................................................................................. 7508 I 

2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) ...................................................................................................... 7509 I 

2C-H (2-(2,5-Dimethoxyphenyl) ethanamine) ................................................................................................................. 7517 I 

2C-I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ........................................................................................................ 7518 I 

2C-C (2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ................................................................................................... 7519 I 

2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ..................................................................................................... 7521 I 

2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .............................................................................................. 7524 I 

2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ..................................................................................... 7532 I 

MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... 7535 I 

25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..................................................... 7536 I 

25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ..................................................... 7537 I 

25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .......................................................... 7538 I 

Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... 7540 I 

Butylone ........................................................................................................................................................................... 7541 I 

Pentylone ......................................................................................................................................................................... 7542 I 

N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .................................................... 7543 I 

a-PHP, alpha-Pyrrolidinohexanophenone ....................................................................................................................... 7544 I 

a-PVP (alpha-pyrrolidinopentiophenone) ........................................................................................................................ 7545 I 

a-PBP (alpha-pyrrolidinobutiophenone) .......................................................................................................................... 7546 I 

PV8, alpha-Pyrrolidinoheptaphenone .............................................................................................................................. 7548 I 

AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) .................................................................................................... 7694 I 

Norfentanyl ...................................................................................................................................................................... 8366 I 

Acetyldihydrocodeine ....................................................................................................................................................... 9051 I 

Benzylmorphine ............................................................................................................................................................... 9052 I 

Codeine-N-oxide .............................................................................................................................................................. 9053 I 

Cyprenorphine ................................................................................................................................................................. 9054 I 

Desomorphine ................................................................................................................................................................. 9055 I 

Etorphine (except HCl) .................................................................................................................................................... 9056 I 

Codeine methylbromide ................................................................................................................................................... 9070 I 

Dihydromorphine ............................................................................................................................................................. 9145 I 

Difenoxin .......................................................................................................................................................................... 9168 I 

Heroin .............................................................................................................................................................................. 9200 I 

Hydromorphinol ............................................................................................................................................................... 9301 I 

Methyldesorphine ............................................................................................................................................................ 9302 I 

Methyldihydromorphine ................................................................................................................................................... 9304 I 

Morphine methylbromide ................................................................................................................................................. 9305 I 

Morphine methylsulfonate ............................................................................................................................................... 9306 I 

Morphine-N-oxide ............................................................................................................................................................ 9307 I 

Myrophine ........................................................................................................................................................................ 9308 I 

Nicocodeine ..................................................................................................................................................................... 9309 I 

Nicomorphine ................................................................................................................................................................... 9312 I 

Normorphine .................................................................................................................................................................... 9313 I 

Pholcodine ....................................................................................................................................................................... 9314 I 

Thebacon ......................................................................................................................................................................... 9315 I 

Acetorphine ...................................................................................................................................................................... 9319 I 

Drotebanol ....................................................................................................................................................................... 9335 I 

U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ............................................................... 9547 I 

AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) .................................................................. 9551 I 

MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ................................................................................................... 9560 I 

Acetylmethadol ................................................................................................................................................................ 9601 I 

Allylprodine ...................................................................................................................................................................... 9602 I 

Alphacetylmethadol except levo-alphacetylmethadol ...................................................................................................... 9603 I 

Alphameprodine ............................................................................................................................................................... 9604 I 

Alphamethadol ................................................................................................................................................................. 9605 I 

Benzethidine .................................................................................................................................................................... 9606 I 

Betacetylmethadol ........................................................................................................................................................... 9607 I 

Betameprodine ................................................................................................................................................................ 9608 I 


jspears on DSK121TN23PROD with NOTICES1
25298 Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 

Controlled substance Drug code Schedule 

Betamethadol ................................................................................................................................................................... 9609 I 

Betaprodine ..................................................................................................................................................................... 9611 I 

Clonitazene ...................................................................................................................................................................... 9612 I 

Dextromoramide .............................................................................................................................................................. 9613 I 

Diampromide ................................................................................................................................................................... 9615 I 

Diethylthiambutene .......................................................................................................................................................... 9616 I 

Dimenoxadol .................................................................................................................................................................... 9617 I 

Dimepheptanol ................................................................................................................................................................. 9618 I 

Dimethylthiambutene ....................................................................................................................................................... 9619 I 

Dioxaphetyl butyrate ........................................................................................................................................................ 9621 I 

Dipipanone ....................................................................................................................................................................... 9622 I 

Ethylmethylthiambutene .................................................................................................................................................. 9623 I 

Etonitazene ...................................................................................................................................................................... 9624 I 

Etoxeridine ....................................................................................................................................................................... 9625 I 

Furethidine ....................................................................................................................................................................... 9626 I 

Hydroxypethidine ............................................................................................................................................................. 9627 I 

Ketobemidone .................................................................................................................................................................. 9628 I 

Levomoramide ................................................................................................................................................................. 9629 I 

Levophenacylmorphan .................................................................................................................................................... 9631 I 

Morpheridine .................................................................................................................................................................... 9632 I 

Noracymethadol ............................................................................................................................................................... 9633 I 

Norlevorphanol ................................................................................................................................................................ 9634 I 

Normethadone ................................................................................................................................................................. 9635 I 

Norpipanone .................................................................................................................................................................... 9636 I 

Phenadoxone ................................................................................................................................................................... 9637 I 

Phenampromide .............................................................................................................................................................. 9638 I 

Phenoperidine .................................................................................................................................................................. 9641 I 

Piritramide ........................................................................................................................................................................ 9642 I 

Proheptazine .................................................................................................................................................................... 9643 I 

Properidine ...................................................................................................................................................................... 9644 I 

Racemoramide ................................................................................................................................................................ 9645 I 

Trimeperidine ................................................................................................................................................................... 9646 I 

Phenomorphan ................................................................................................................................................................ 9647 I 

Propiram .......................................................................................................................................................................... 9649 I 

1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 9661 I 

1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .............................................................................................................. 9663 I 

Tilidine ............................................................................................................................................................................. 9750 I 

Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ................................................................................. 9811 I 

Para-Fluorofentanyl ......................................................................................................................................................... 9812 I 

3-Methylfentanyl .............................................................................................................................................................. 9813 I 

Alpha-Methylfentanyl ....................................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ............................................................................................................................................. 9815 I 

N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ....................................................................................... 9816 I 

Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... 9821 I 

Butyryl Fentanyl ............................................................................................................................................................... 9822 I 

Para-fluorobutyryl fentanyl ............................................................................................................................................... 9823 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................... 9824 I 

2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ......................................................................................... 9825 I 

Para-chloroisobutyryl fentanyl ......................................................................................................................................... 9826 I 

Isobutyryl fentanyl ............................................................................................................................................................ 9827 I 

Beta-hydroxyfentanyl ....................................................................................................................................................... 9830 I 

Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ 9831 I 

Alpha-methylthiofentanyl ................................................................................................................................................. 9832 I 

3-Methylthiofentanyl ......................................................................................................................................................... 9833 I 

Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. 9834 I 

Thiofentanyl ..................................................................................................................................................................... 9835 I 

Beta-hydroxythiofentanyl ................................................................................................................................................. 9836 I 

Para-methoxybutyryl fentanyl .......................................................................................................................................... 9837 I 

Ocfentanil ......................................................................................................................................................................... 9838 I 

Valeryl fentanyl ................................................................................................................................................................ 9840 I 

N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) ......................................................................... 9843 I 

Cyclopropyl Fentanyl ....................................................................................................................................................... 9845 I 

Cyclopentyl fentanyl ........................................................................................................................................................ 9847 I 

Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ..................................................................................... 9850 I 

Amphetamine ................................................................................................................................................................... 1100 II 

Methamphetamine ........................................................................................................................................................... 1105 II 

Lisdexamfetamine ............................................................................................................................................................ 1205 II 

Phenmetrazine ................................................................................................................................................................. 1631 II 

Methylphenidate .............................................................................................................................................................. 1724 II 

Amobarbital ...................................................................................................................................................................... 2125 II 

Pentobarbital .................................................................................................................................................................... 2270 II 

Secobarbital ..................................................................................................................................................................... 2315 II 

Glutethimide ..................................................................................................................................................................... 2550 II 

Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration 

(FDA).

7365 II 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 82 / Thursday, April 28, 2022 / Notices 25299 

Controlled substance Drug code Schedule 

Nabilone ........................................................................................................................................................................... 7379 II 

1-Phenylcyclohexylamine ................................................................................................................................................ 7460 II 

Phencyclidine ................................................................................................................................................................... 7471 II 

ANPP (4-Anilino-N-phenethyl-4-piperidine) ..................................................................................................................... 8333 II 

Phenylacetone ................................................................................................................................................................. 8501 II 

1-Piperidinocyclohexanecarbonitrile ................................................................................................................................ 8603 II 

Alphaprodine .................................................................................................................................................................... 9010 II 

Anileridine ........................................................................................................................................................................ 9020 II 

Cocaine ............................................................................................................................................................................ 9041 II 

Codeine ........................................................................................................................................................................... 9050 II 

Etorphine HCl .................................................................................................................................................................. 9059 II 

Dihydrocodeine ................................................................................................................................................................ 9120 II 

Oxycodone ....................................................................................................................................................................... 9143 II 

Hydromorphone ............................................................................................................................................................... 9150 II 

Diphenoxylate .................................................................................................................................................................. 9170 II 

Ecgonine .......................................................................................................................................................................... 9180 II 

Ethylmorphine .................................................................................................................................................................. 9190 II 

Hydrocodone ................................................................................................................................................................... 9193 II 

Levomethorphan .............................................................................................................................................................. 9210 II 

Levorphanol ..................................................................................................................................................................... 9220 II 

Isomethadone .................................................................................................................................................................. 9226 II 

Meperidine ....................................................................................................................................................................... 9230 II 

Meperidine-intermediate-A .............................................................................................................................................. 9232 II 

Meperidine intermediate-B .............................................................................................................................................. 9233 II 

Meperidine intermediate-C .............................................................................................................................................. 9234 II 

Metazocine ...................................................................................................................................................................... 9240 II 

Methadone ....................................................................................................................................................................... 9250 II 

Methadone intermediate .................................................................................................................................................. 9254 II 

Metopon ........................................................................................................................................................................... 9260 II 

Dextropropoxyphene, bulk (non-dosage forms) .............................................................................................................. 9273 II 

Morphine .......................................................................................................................................................................... 9300 II 

Oripavine ......................................................................................................................................................................... 9330 II 

Thebaine .......................................................................................................................................................................... 9333 II 

Dihydroetorphine ............................................................................................................................................................. 9334 II 

Levo-alphacetylmethadol ................................................................................................................................................. 9648 II 

Oxymorphone .................................................................................................................................................................. 9652 II 

Noroxymorphone ............................................................................................................................................................. 9668 II 

Phenazocine .................................................................................................................................................................... 9715 II 

Thiafentanil ...................................................................................................................................................................... 9729 II 

Piminodine ....................................................................................................................................................................... 9730 II 

Racemethorphan ............................................................................................................................................................. 9732 II 

Racemorphan .................................................................................................................................................................. 9733 II 

Alfentanil .......................................................................................................................................................................... 9737 II 

Remifentanil ..................................................................................................................................................................... 9739 II 

Sufentanil ......................................................................................................................................................................... 9740 II 

Carfentanil ....................................................................................................................................................................... 9743 II 

Tapentadol ....................................................................................................................................................................... 9780 II 

Bezitramide ...................................................................................................................................................................... 9800 II 

Fentanyl ........................................................................................................................................................................... 9801 II 

Moramide-intermediate .................................................................................................................................................... 9802 II 

The company plans to import 

analytical reference standards for 

distribution to its customers for research 

and analytics purposes. Placement of 

these drug codes onto the company’s 

registration does not translate into 

automatic approval of subsequent 

permit applications to import controlled 

substances. Approval of permit 

applications will occur only when the 

registrant’s business activity is 

consistent with what is authorized in 21 

U.S.C. 952(a)(2). Authorization will not 

extend to the import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–09062 Filed 4–27–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–995] 

Bulk Manufacturer of Controlled 

Substances Application: SpecGx LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: SpecGx LLC has applied to be 

registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before June 27, 2022. Such 

persons may also file a written request 

for a hearing on the application on or 

before June 27, 2022. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 


jspears on DSK121TN23PROD with NOTICES1